Rigel Pharmaceuticals Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 73.7 | 17.3 | 8.8 | 3.5 | 4.8 | 2.2 | 1.5 | 2.4 | |
| 13.6 | 11.7 | 19.8 | 23.7 | 28.2 | 48.3 | 63.8 | 72.1 | 52.0 | 8.7 | 7.6 | 6.6 | 3.9 | 5.9 | 2.6 | 2.8 | 3.8 | 5.4 | 4.5 | 5.1 | 4.2 | 3.1 | 6.1 | 2.1 | 2.3 | 2.2 | 1.7 | 1.8 | 1.4 | 2.2 | 2.2 | 1.1 | 1.8 | 1.7 | 1.6 | 1.3 | 1.9 | 2.7 | 1.8 | 2.8 | |
| 5.4 | 4.3 | 4.5 | 4.8 | 5.5 | 5.6 | 6.5 | 3.7 | 5.1 | 3.5 | 4.6 | 5.6 | 4.6 | 6.5 | 3.4 | 4.8 | 8.0 | 17.4 | 7.6 | 10.7 | 12.4 | 15.2 | 75.8 | – | – | – | – | – | – | – | – | – | – | 91.9 | 17.6 | 4.1 | 4.6 | 2.1 | 1.3 | 1.8 | |
| 12.7 | 10.9 | 17.8 | 21.6 | 25.9 | 45.0 | 58.8 | 61.8 | 46.0 | – | 6.9 | 6.0 | 3.6 | 5.8 | 2.4 | 2.7 | 3.8 | 5.4 | 4.5 | 4.7 | 4.2 | 3.2 | 6.2 | 2.2 | 2.5 | 2.3 | 1.9 | 1.9 | 1.6 | 2.5 | 2.5 | 1.3 | 1.9 | 1.7 | 1.7 | 1.3 | 2.0 | 2.8 | 1.8 | 2.7 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 21.5 | 10.7 | 7.0 | 3.2 | 4.5 | 6.2 | 4.2 | 7.9 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 74.7 | 88.0 | – | – | – | – | – | – | – | – | – | – | 27.6 | 9.7 | 9.3 | 5.2 | 8.0 | 10.7 | 6.7 | 9.6 | |
| -22.1% | -32.3% | -19.9% | -22.9% | -22.6% | -13.8% | -15.6% | -19.6% | -17.1% | -15.5% | -8.6% | -6.1% | -6.6% | -12.2% | -17.0% | -14.2% | -11.7% | -9.0% | -11.7% | -0.1% | 1.3% | 1.1% | -0.1% | -36.1% | -34.4% | -28.6% | -29.9% | -21.5% | -19.0% | -7.9% | -2.6% | -8.8% | 3.6% | 10.3% | 10.8% | 19.4% | 12.6% | 9.4% | 14.9% | 10.4% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| -163.8% | -211.3% | -204.4% | -297.0% | -351.1% | -358.6% | -548.3% | -493.6% | -158.8% | 74.1% | 99.3% | 99.0% | 98.9% | 98.5% | 99.1% | 99.1% | 99.3% | 99.2% | 99.2% | 99.4% | 99.4% | 99.3% | 99.0% | 98.0% | 97.9% | 98.5% | 98.0% | 97.9% | 97.2% | 93.9% | 93.2% | 92.4% | 89.4% | 89.6% | 89.6% | 91.5% | 93.1% | 93.3% | 93.4% | 91.4% | |
| -257.3% | -342.2% | -361.1% | -531.8% | -625.1% | -683.3% | -1,092.6% | -1,513.6% | -990.9% | -163.3% | -116.1% | -93.6% | -60.2% | -116.5% | -29.0% | -23.8% | -26.0% | -26.7% | -6.2% | -2.7% | -6.7% | -8.4% | -94.8% | -90.9% | -88.4% | -46.2% | -32.4% | -27.1% | -15.4% | -17.5% | -12.2% | -6.9% | 6.0% | 13.5% | 21.6% | 39.0% | 42.2% | 42.6% | 41.6% | 31.5% | |
| -255.8% | -339.6% | -354.1% | -521.8% | -611.8% | -669.3% | -1,079.1% | -1,490.6% | -972.8% | -158.3% | -111.5% | -89.3% | -56.8% | -112.8% | -27.4% | -23.2% | -26.2% | -27.4% | -8.6% | -5.4% | -9.9% | -12.0% | -99.9% | -95.5% | -92.4% | -48.7% | -34.5% | -29.8% | -18.5% | -21.5% | -16.5% | -10.9% | 2.5% | 9.8% | 18.3% | 36.5% | 40.2% | 124.7% | 121.5% | 116.3% | |
| -301.5% | -376.3% | -394.7% | -542.6% | -636.3% | -667.0% | -997.9% | -1,414.5% | -891.7% | -134.7% | -65.3% | -40.1% | -25.8% | -72.5% | -44.6% | -39.8% | -45.1% | -49.2% | -52.1% | -0.7% | 5.6% | 3.5% | -0.7% | -77.1% | -79.8% | -61.7% | -52.0% | -38.4% | -27.6% | -17.7% | -5.7% | -9.7% | 6.6% | 17.3% | 17.4% | 24.6% | 24.2% | 25.7% | 26.4% | 28.7% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -100.6% | -125.8% | -79.8% | -104.4% | -120.6% | -77.5% | -109.1% | -75.6% | -96.2% | -64.1% | -66.8% | -75.0% | -67.4% | -124.3% | -35.7% | -39.6% | -54.4% | -87.4% | -14.7% | -11.4% | -29.2% | -59.0% | -1,248.3% | – | – | – | – | – | – | – | – | – | – | 531.8% | 200.2% | 119.4% | 96.3% | 93.8% | 91.1% | 75.7% | |
| -74.8% | -88.6% | -66.2% | -85.0% | -95.0% | -65.5% | -88.1% | -66.2% | -80.8% | -50.7% | -36.9% | -37.6% | -29.8% | -45.3% | -19.6% | -18.1% | -22.5% | -26.9% | -5.3% | -3.8% | -7.8% | -10.7% | -56.9% | -66.0% | -71.5% | -43.6% | -36.1% | -32.3% | -21.2% | -21.4% | -15.7% | -11.1% | 2.8% | 10.7% | 21.1% | 47.3% | 46.7% | 71.5% | 72.2% | 61.8% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -23 | -14 | -37 | -30 | -25 | -38 | -40 | -65 | -61 | – | -43 | -37 | -22 | -5.4 | -28 | -8.6 | -8.4 | -1.9 | 8.7 | -56 | -0.9 | 11 | 13 | 8.4 | 13 | 16 | 20 | 11 | 15 | 28 | 35 | 24 | 8.5 | 3.2 | 14 | 6.9 | 12 | 12 | 21 | -21 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.6 | 0.1 | 0.3 | 0.1 | 0.1 | 0.1 | 0.2 | -0.2 | |
| 74.4% | 70.4% | 83.0% | 81.4% | 78.8% | 84.5% | 80.8% | 87.5% | 84.0% | 79.0% | 55.2% | 50.1% | 44.2% | 36.5% | 54.8% | 45.8% | 41.4% | 30.8% | 36.3% | 33.8% | 26.6% | 18.2% | 4.6% | -2.9% | -17.2% | -10.1% | -19.6% | -24.0% | -27.6% | -24.4% | -25.0% | -23.3% | -10.5% | 2.0% | 10.6% | 39.6% | 48.5% | 76.2% | 79.2% | 81.6% | |
| 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.3 | 0.1 | 0.2 | 0.3 | 0.2 | 0.4 | 0.6 | 0.8 | 0.4 | 0.4 | 0.6 | 1.0 | 5.6 | – | – | – | – | – | – | – | – | – | – | 18.2 | 3.2 | 0.7 | 0.5 | 0.1 | 0.1 | 0.1 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -6.95 | -6.99 | -5.90 | -5.93 | -5.43 | -5.41 | -5.92 | -5.78 | -5.98 | -4.20 | -3.81 | -3.51 | -2.77 | -3.99 | -1.66 | -1.48 | -1.64 | -1.76 | -0.65 | -0.45 | -0.85 | -1.05 | -4.94 | -4.91 | -4.78 | -3.39 | -2.57 | -2.18 | -1.40 | -1.44 | -1.13 | -0.81 | 0.22 | 0.97 | 2.05 | 5.39 | 5.91 | 19.48 | 18.50 | 16.45 | |
| 2.72 | 2.06 | 1.67 | 1.14 | 0.89 | 0.81 | 0.55 | 0.39 | 0.61 | 2.66 | 3.42 | 3.93 | 4.88 | 3.54 | 6.08 | 6.41 | 6.25 | 6.43 | 7.60 | 8.47 | 8.62 | 8.72 | 4.95 | 5.14 | 5.17 | 6.96 | 7.47 | 7.30 | 7.59 | 6.70 | 6.87 | 7.42 | 8.92 | 9.97 | 11.18 | 14.75 | 14.73 | 15.62 | 15.23 | 14.14 | |
| 6.91 | 5.56 | 7.40 | 5.68 | 4.51 | 6.98 | 5.42 | 7.65 | 6.22 | 6.56 | 5.70 | 4.68 | 4.11 | 3.21 | 4.66 | 3.75 | 3.02 | 2.01 | 4.45 | 4.00 | 2.91 | 1.78 | 0.40 | -0.21 | -1.15 | -0.79 | -1.40 | -1.62 | -1.83 | -1.64 | -1.81 | -1.70 | -0.83 | 0.18 | 1.02 | 4.51 | 6.14 | 20.78 | 20.31 | 21.74 | |
| -8.19 | -7.75 | -6.58 | -6.17 | -5.65 | -5.39 | -5.47 | -5.49 | -5.48 | -3.58 | -2.23 | -1.58 | -1.26 | -2.56 | -2.71 | -2.55 | -2.82 | -3.16 | -3.96 | -0.06 | 0.48 | 0.31 | -0.03 | -3.97 | -4.12 | -4.29 | -3.88 | -2.80 | -2.09 | -1.19 | -0.39 | -0.72 | 0.59 | 1.73 | 1.94 | 3.62 | 3.56 | 4.02 | 4.03 | 4.06 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.